Svetlana Mojsov

Svetlana Mojsov is a Yugoslav-born, Macedonian American chemist whose study of glucagon-like peptide-1 (GLP-1) led to her uncovering its role in glucose metabolism and the secretion of insulin. Her research, which focuses on peptide synthesis, led to breakthroughs with GLP-1 and was the foundation used by Novo Nordisk to create therapeutic agents to combat diabetes and obesity. She is a Lulu Chow Wang and Robin Chemers Neustein Research Professor at Rockefeller University.